Research/art/teacher profile of a person
Name and surname:
prof. MUDr. Peter Turčáni, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Turčáni
I.2 - Name
Peter
I.3 - Degrees
Prof., MUDr., PhD.
I.4 - Year of birth
1953
I.5 - Name of the workplace
Comenius University in Bratislava, Ist. Department of Neurology of Medical Faculty anf University Hospital Bratislava
I.6 - Address of the workplace
Mickiewiczova 13, 813 69 Bratislava
I.7 - Position
head of department
I.8 - E-mail address
turcani1@gmail.com
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/3437
I.10 - Name of the study field in which a person works at the university
Neurology
I.11 - ORCID iD
0000-0002-4868-6836

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Medical Faculty
II.b - Year
1977
II.c - Study field and programme
General Medicine
II.2 - Second degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Medical Faculty
II.b - Year
1977
II.c - Study field and programme
General Medicine
II.3 - Third degree of higher education
II.a - Name of the university or institution
Medical Faculty, Pavol Jozef Šafárik University in Košice
II.c - Study field and programme
Pharmacology
II.4 - Associate professor
II.a - Name of the university or institution
Medical Faculty, Comenius University Bratislava
II.b - Year
1993
II.c - Study field and programme
Neurology
II.5 - Professor
II.a - Name of the university or institution
Medical Faculty, Comenius University Bratislava
II.b - Year
1997
II.c - Study field and programme
Neurology
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
PhD student Institute of experimental Pharmacology, Slovak Academy of Sciences 1977 - 1981
University techer - Assistant Professor, Associate Professor, Professor Ist Deparment of Neurology, Medical Faculty, Comenius Univerity Bratislava and University Hospital Bratislava 1981 - lasts
physician- neurologist University Hospital Bratislava 1981 - lasts

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Specialized study of university pedagogy Institute of Information and Prognoses of Education, Youth and Sport, Bratislava 1990
Board Postgraduate Certification 1st Degree - Neurology Slovak Medical University, Bratislava 1989
Board Postgraduate Certification 2nd Degree - Neurology Slovak Medical University, Bratislava 1993
Specialization in specialty Healthcare Management and Financing Comenius University in Bratislava, Medical Faculty, 2015

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Neurology1 General Medicine I,+II, General Medicine
Neurology 2 General Medicine I.+II. General Medicine
Neurology Dental Medicine I.+II. Dental Medicine
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.2.a - Name of the study programme V.2.b - Degree V.2.c - Field of study
General Medicine - guarantor for Neurology I.+II. General Medicine
Dental Medicine - guarantor for Neurology I.+II. Dental Medicine
Neurology - guarantor III. General Medicine
Specialty study programme Neurology - guarantor other General Medicine
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.3.a - Name of the field of habilitation procedure and inaugural procedure V.3.b - Study field to which it is assigned
Neurology- guarantor General Medicine
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.b - Diploma (second degree)
1
V.4.c - Dissertation (third degree)
1
V.4.2 - Number of defended theses
V.4.b - Diploma (second degree)
2
V.4.c - Dissertation (third degree)
14
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Neurology Specialty study programme in the specialty fields of endocrinology, gastroenterology, geriatrics, clinical immunology and allergology, clinical oncology, internal medicine other General Medicine
Neurology Specialty study programme in specialty field ophtalmology other General Medicine
Neurology Specialty study programme in specialty field psychiatry other General Medicine

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
681
VI.1.b - Over the last six years
81
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
191
VI.1.b - Over the last six years
51
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
1893
VI.1.b - Over the last six years
262
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
9685
VI.1.b - Over the last six years
794
VI.1.5 - Number of invited lectures at the international, national level
VI.2 - The most significant research/artistic/other outputs
1

Tomita M, Gotoh F, Tanahashi N, Turcani P.

Whole-blood red blood cell aggregometer for human and feline blood

American Journal of Physiology-Heart and Circulatory Physiology. - Vol. 251, No. 6 (1986), s. H1205-H1210

2

Turcani P, Gotoh, F, Ishihara N, Tanaka K, Gomi S, Takashima S, Mihara B.

Dual effect of naloxone on blood plateled aggregation and cerebral blood flow in gerbils

Thrombosis Research. - Vol. 44, No. 6 (1986), s. 817-828

3

Turcani P, Gotoh, F, Ishihara N, Tanaka K, Gomi S, Takashima S, Mihara B.

Are blood platelets involved in the pathogenesis of ischemic brain edema in gerbils?

Stroke. - Vol. 19, No. 4 (1988), s. 486-489

4

Turcani P, Turcani M.

Effect of propentofylline on cerebral blood flow in a gerbil focal cerebral ischemia.

J Neurol Sci. 2001 Jan 15;183(1):57-60. doi: 10.1016/s0022-510x(00)00477-9. PMID: 11166795.

5

The Committee for Advanced Therapies (CAT) - Schneider CK, Salmikangas P, Jilma B, Flamion B, Todorova LR, Paphitou A, Haunerova I, Maimets T, Flory E, Turcani P. et al:

Challenges with advanced therapy medicinal products and how to meet them

Nature Reviews Drug Discovery. - Vol. 9, No. 3 (2010), s. 195-201. - ISSN 1474-1776,

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Hardonova M, Siarnik P, Sivakova M, Sucha B, Penesova A, Radikova Z, Havranova A, Imrich R, Vlcek M, Zitnanova I, Krastev G, Kiacikova M, Kollar B, Turcani P.

Endothelial Function in Patients with Multiple Sclerosis: The Role of GLP-1 Agonists, Lipoprotein Subfractions, and Redox Balance.

Int J Mol Sci. 2023 Jul 6;24(13):11162. doi: 10.3390/ijms241311162. PMID: 37446338; PMCID: PMC10342844.

2

Turčáni P, Mašková J, Húska J.

Real-World Treatment Patterns of Disease Modifying Therapy (DMT) for Patients with Relapse-Remitting Multiple Sclerosis and Patient Satisfaction with Therapy: Results of the Non-Interventional SKARLET Study in Slovakia.

Patient preference and adherence vol. 14 1129-1135. 7 Jul. 2020, doi:10.2147/PPA.S254427

3

Berger T, Adamczyk-Sowa M, Csépány T, Fazekas F, Fabjan TH, Horáková D, Ledinek AH, Illes Z, Kobelt G, Jazbec SŠ, Klímová E, Leutmezer F, Rejdak K, Rozsa C, Sellner J, Selmaj K, Štouracˇ P, Szilasiová J, Turcˇáni P, Vachová M, Vanecková M, Vécsei L, Havrdová EK.

Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease.

Ther Adv Neurol Disord. 2020 Dec 7;13:1756286420975223. doi: 10.1177/1756286420975223. PMID: 33335562; PMCID: PMC7724259.

4

Habek M, Drulovic J, Brecl Jakob G, Barbov I, Radulovic L, Rajda C, Rejdak K, Turčáni P.

Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers.

Neurol Ther. 2023 Feb;12(1):25-37. doi: 10.1007/s40120-022-00422-z. Epub 2022 Nov 17. PMID: 36394714; PMCID: PMC9672547.

5

Shoamanesh A, Mundl H, Smith EE, Masjuan J, Milanov I, Hirano T, Agafina A, Campbell B, Caso V, Mas JL, Dong Q, Turcani P, Christensen H, Ferro JM, Veltkamp R, Mikulik R, De Marchis GM, Robinson T, Lemmens R, Stepien A, Greisenegger S, Roine R, Csiba L, Khatri P, Coutinho J, Lindgren AG, Demchuk AM, Colorado P, Kirsch B, Neumann C, Heenan L, Xu L, Connolly SJ, Hart RG; PACIFIC-Stroke Investigators.

Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial.

Lancet. 2022 Sep 24;400(10357):997-1007. doi: 10.1016/S0140-6736(22)01588-4. Epub 2022 Sep 2. PMID: 36063821.

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Beris AN, Horner JS, Jariwala S, Armstrong MJ, Wagner NJ. Recent advances in blood rheology: a review. Soft Matter. 2021;17(47):10591-10613. doi:10.1039/D1SM01212F

(Tomita M, Gotoh F, Tanahashi N, Turcani P. Whole-blood red blood cell aggregometer for human and feline blood. Am J Physiol-Heart Circ Physiol. 1986;251(6):H1205-H1210. doi:10.1152/ajpheart.1986.251.6.H1205)

2

Olinger CP, Adams HP, Brott TG, et al. High-dose intravenous naloxone for the treatment of acute ischemic stroke. Stroke. 1990;21(5):721-725. doi:10.1161/01.STR.21.5.721

(Turcani P, Gotoh F, Ishihara N, et al. Dual effect of naloxone on blood platelet aggregation and cerebral blood flow in gerbils. Thromb Res. 1986;44(6):817-828. doi:10.1016/0049-3848(86)90027-7)

3

Schaller B, Graf R. Cerebral Venous Infarction: The Pathophysiological Concept. Cerebrovasc Dis. 2004;18(3):179-188. doi:10.1159/000079939

(Turcani P, Gotoh F, Ishihara N, et al. Are blood platelets involved in the pathogenesis of ischemic brain edema in gerbils? Stroke. 1988;19(4):486-489. doi:10.1161/01.STR.19.4.486)

4

Pedata F, Dettori I, Coppi E, et al. Purinergic signalling in brain ischemia. Neuropharmacology. 2016;104:105-130. doi:10.1016/j.neuropharm.2015.11.007

(Turcani P, Turcani M. Effect of propentofylline on cerebral blood flow in a gerbil focal cerebral ischemia. J Neurol Sci. 2001;183(1):57-60. doi:10.1016/S0022-510X(00)00477-9)

5

Hillert J, Magyari M, Soelberg Sørensen P, et al. Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network. Front Neurol. 2021;12:647811. doi:10.3389/fneur.2021.647811

(Turčáni P, Mašková J, Húska J. Real-World Treatment Patterns of Disease Modifying Therapy (DMT) for Patients with Relapse-Remitting Multiple Sclerosis and Patient Satisfaction with Therapy: Results of the Non-Interventional SKARLET Study in Slovakia. Patient Prefer Adherence. 2020;Volume 14:1129-1135. doi:10.2147/PPA.S254427)

 

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

2016 - 2021 Slovak Research and Development Agency, grant number APVV-15-0253: Molecular mediators of physical exercise and carnosine-induced effects in patients with preclinical and early stage neurodegenerative disease. Principal Investigator: prof. MUDr. Peter Turčáni, PhD.

2

2018 - 2021 Ministry of Health of the Slovak Republic, grant number MZ-SR 2018/37-LFUK-11: The use of GLP-1 analogs in the multiple sclerosis treatment. Principal investigator: prof. MUDr. Peter Turčáni, PhD.

3

2022 - 2026 Slovak Research and Development Agency, grant number APVV-21-0261: Effects of GLP-1 analogs on Multiple sclerosis. Principal investigator: prof. MUDr. Peter Turčáni, PhD.

4

2023 - 2026 Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic, VEGA 1/0022/23: Potential risk factors for accelerated atherogenesis in patients with obstructive sleep apnea. Principal investigator: Assoc. Prof. Pavel Šiarnik, MD, PhD, MPH., Investigator: prof. MUDr. Peter Turčáni, PhD.

5

2024 - 2028 Sloval Research and Development Agency, grant number APVV-23- 0028: „Innovative and comprehensive insight into obstructive sleep apnea. Principal investigator: Prof. Branislav Kollár, MD, PhD, MPH., Investigator: prof. MUDr. Peter Turčáni, PhD.

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
vice-dean for science and research Comenius University, Medical Faculty 2003 - 2007
Committee of the PhD study program in neurology - chairman Comenius University, Medical Faculty 2008 - lasts
Committee of the PhD study program in neurology - member Pavol Jozef Šafárik University in Košice, Medical Faculty 2014 - lasts
Scientific Board Comenius University, Medical Faculty 2003 - lasts
Chief Advisor for Neurology to the Minister of Health Ministry of Health 2007 - lasts
Scientific Board - chairman Slovak Medical Chamber 2007 - lasts
Active member Class II - Medicine European Academy of Sciences and Arts 2014 - lasts
Committee for Advanced Therapy - member European Medicine Agency 2010 - 2013
Editorial Board - secretary, member Czech and Slovak Neurology and Neurosurgery 1981 - trvá
Editorial Board - associate editor New Trends in Clinical Neuropharmacology 1988 - 1995

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
Keio University, School of Medicine, Department of Neurology 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582 1983-1985 Monbusho scholarship, visiting researcher
University of Bonn, Faculty of Medicie, Neurological Clinic Venusberg-Campus 1, 531 27 Bonn 1987 DAAD scholarship, visiting researcher

IX. - Other relevant facts

IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned

Patents

Rybár, A. - Tegza, M. - Repáš, M. - Hesek, D. - Frim, R. - Szemes, F. - Guttmann, M. - Turčáni, P. - Mahrla, Z.: Method for preparation of 3-methyl-1-(5-oxohexyl)-7-n-propyl-3,7-dihydro-1-H-purine-2,6-dione: Authors certificate for invention No: 270 546. - Praha : Federální úřad pro vynálezy, 1991

Rybár, A. - Tegza, M. - Repáš, M. - Hesek, D. - Frim, R. - Szemes, F. - Guttmann, M. - Turčáni, P. - Mahrla, Z.: Method for preparation of 3-methyl-1-(5-oxohexyl)-7-n-propyl-3,7-dihydro-1-H-purine-2,6-dione: Authors certificate for invention No: 270 547. - Praha : Federální úřad pro vynálezy, 1991

Rybár, A. - Turčáni, P.: 1-Oxoalkylxantins and mode of their preparation: Authors certificate for invention No: 277 931. - Bratislava: Industrial Property Office of Slovak Republic 09. 08. 1995

Award of the Slovak Neurological Society /SNeS/ for the best publication in 1985

Award of the Slovak Neurological Society /SNeS/ for the best publication in 2014

Award of the Slovak Neurological Society /SNeS/ for the best publication in 2020

Gold Medal of the Slovak Medical Society

Silver Medal of the Medical Faculty of Comenius University in Bratislava

Gold Medal of the Medical Faculty of Comenius University in Bratislava

Commemorative medal of the Medical Faculty of Comenius University in Bratislava on the 100-th anniversary of its founding

Commemorative Medal on the Occasion of the 160th Anniversary of the Establishment of the Staré Mesto Hospital on Mickiewiczova Street

Awarding of scientific qualification grade VKS-IIa (Slovak Academy of Sciences, 1987)

Date of last update
2025-02-04